Keywords: bayer, acarbose, gains, panel, backing, treatment, alpha

Bayer's Acarbose Gains US Panel Backing

Article | 12 June 1995

Treatment with Bayer's alpha glucosidase inhibitor Precose (acarbose) achieves a clinically significant reduction in glycosylated hemoglobin levels in patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Acarbose

Precose

Aspirin

Bayer

Alpha

Go to drug listing